Keep up to date with the latest news from Accelagen
Leading the future of Biostatistics at Accelagen: Meet our experienced new Head of Biostatistics, Rebecca Asher
Leading the future of Biostatistics at Accelagen: Meet our experienced new Head of Biostatistics, Rebecca Asher Australia’s biotech sector is growing rapidly, and Accelagen is proud to be leading the way. Meet our experienced new Head of Biostatistics, Rebecca Asher.Behind…
The people powering progress: Meet Accelagen’s latest CRA recruits
Meet some of Accelagen’s newest CRAs—passionate, driven and ready to make a real-world impact. Get to know the team shaping the future of clinical research.
Accelerating Equity: Women in Biotech and creating an inclusive workplace culture
Accelerating Equity: Women in Biotech and Creating an Inclusive Workplace Culture With nearly 70% of its workforce being women, Accelagen is redefining biotech by fostering equity, flexibility, and career growth in STEM.Despite some progress, women remain underrepresented in leadership roles…
Putting people first: Dr. Eleanor Guest joins Accelagen’s Executive Leadership Team
Putting people first: Dr. Eleanor Guest joins Accelagen’s Executive Leadership Team Accelagen welcomes Dr. Eleanor Guest as Executive Director of Operations, bringing 14+ years of clinical research expertise to drive growth and innovation.As a CRO, our work is paved by milestones—and…
Welcoming our new Business Planning and Analysis Manager
Welcoming our new Business Planning and Analysis Manager Accelagen is delighted to announce David Stella as our new Business Planning and Analysis Manager. With over a decade of experience in financial planning and analysis, David joins us from IDP Education,…
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results
Accelagen accelerates time to market for European clients: Potentially best-in-class study for Treatment of BKV Infection sees exciting results Local CRO, Accelagen, attracts innovative European drug and antibody developers to trial in Australian marketEngaged by world-renowned European clients and collaborators,…
Accelagen Staff Announcement: Amritha Vangur
Accelagen Staff Announcement: Amritha Vangur The Accelagen family is growing…again!Today we are thrilled to announce that Amritha Vangur has rejoined our team as Clinical Research Associate.Amritha first worked at Accelagen in 2019. The company was in its infancy at the…
Accelagen Staff Announcement: Suzanne Leong
Accelagen Staff Announcement: Suzanne Leong We are excited to formally welcome another highly experienced team member to Accelagen’s fast-growing Australian team, Suzanne Leong.Joining the Accelagen team is Suzanne Leong, the company’s new Senior Clinical Data Manager, bringing with her over…
Accelagen Staff Announcement: Sian Gilmour
Accelagen Staff Announcement: Sian Gilmour One of the things we love most about our work is helping people to learn and develop their careers along whatever path they are inspired to pursue.Today we are excited to share that we have…